B4galnt3tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
B4galnt3tm1d(EUCOMM)Wtsi |
Name: |
beta-1,4-N-acetyl-galactosaminyl transferase 3; targeted mutation 1d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:7509340 |
Gene: |
B4galnt3 Location: Chr6:120180034-120271520 bp, - strand Genetic Position: Chr6, 56.94 cM
|
Alliance: |
B4galnt3tm1d(EUCOMM)Wtsi page
|
IMPC: |
B4galnt3 gene page |
|
Germline Transmission: |
Earliest citation of germline transmission:
J:337847
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 120198699 of Chromosome 6 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 120199784. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:337847)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any B4galnt3 Mutation: |
45 strains or lines available
|
|
Original: |
J:337847 Moverare-Skrtic S, et al., B4GALNT3 regulates glycosylation of sclerostin and bone mass. EBioMedicine. 2023 May;91:104546 |
All: |
1 reference(s) |
|